Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

NCT06048367 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor
Lung Cancer
Pancreas Cancer
Breast Cancer
Thyroid Cancer
Colorectal Cancer
Cervical Cancer
Ovarian Cancer
Vulva Cancer

Interventions

DRUG: CNSI-Fe(II) 30 mg
DRUG: CNSI-Fe(II) 60 mg
DRUG: CNSI-Fe(II) 90 mg
DRUG: CNSI-Fe(II) 120 mg
DRUG: CNSI-Fe(II) 150 mg

Sponsor

Sichuan Enray Pharmaceutical Sciences Company